Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

So Far, So Good for PCSK9-Targeting Gene Therapy in Hypercholesterolemia

So Far, So Good for PCSK9-Targeting Gene Therapy in Hypercholesterolemia
ShareXFacebook

(MedPage Today) -- An investigational gene therapy passed muster for reducing PCSK9 and LDL cholesterol levels, with reassuring safety, among patients with heterozygous familial hypercholesterolemia (HeFH) or premature coronary artery disease ...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement